Pharmacists to the rescue: new study aims to protect kidneys in diabetes patients without a family doctor

NCT ID NCT07169422

Recruiting now Disease control Sponsor: Nova Scotia Health Authority Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether specially trained community pharmacists can help people with type 2 diabetes and early kidney disease start and stick with medications that protect the kidneys and heart. The trial will include 120 adults in Nova Scotia who don't have a family doctor. Participants will either get pharmacist-led care using a step-by-step guide or usual care from walk-in or virtual clinics. The goal is to see if pharmacist prescribing improves use of these life-saving drugs and is safe.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome diabetic kidney disease type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE DIABETIC KIDNEY DISEASE TYPE 2 DIABETES

Contacts and locations

Locations

Dalhousie University
RECRUITING

Halifax, Nova Scotia, b3h 2y9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.